Contents

Current Cancer Drug Targets, Volume 12 - Number 3

Editorial [Hot Topic: Target Therapy in Brain Tumours and Metastases (Guest Editors: M. Caraglia and R. Addeo)]

, 12(3): 185

M. Caraglia and R. Addeo


DOI: 10.2174/156800912799277458




Nanotech Revolution for the Anti-Cancer Drug Delivery through Blood- Brain-Barrier

, 12(3): 186 - 196

M. Caraglia, G. De Rosa, G. Salzano, D. Santini, M. Lamberti, P. Sperlongano, A. Lombardi, A. Abbruzzese and R. Addeo


DOI: 10.2174/156800912799277421




Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance

, 12(3): 197 - 209

T. E. Taylor, F. B. Furnari and W. K. Cavenee


DOI: 10.2174/156800912799277557




New Target Therapies for Brain Metastases from Breast Cancer

, 12(3): 210 - 217

G. Metro and A. Fabi


DOI: 10.2174/156800912799277548




Targeted Therapy for Brain Tumours: Role of PARP Inhibitors

, 12(3): 218 - 236

C. Leonetti, A. Biroccio, G. Graziani and L. Tentori


DOI: 10.2174/156800912799277403




Role of EGFR Inhibitors in the Treatment of Central Nervous System Metastases from Non-Small Cell Lung Cancer

, 12(3): 237 - 246

G. L. Ceresoli


DOI: 10.2174/156800912799277430




The Blood-Brain Barrier: Its Influence in the Treatment of Brain Tumors Metastases

, 12(3): 247 - 259

D. Fortin


DOI: 10.2174/156800912799277511




Non-Cytotoxic Radiosensitizers in Brain Radiotherapy: Journey Till the First Decade of this Millennium

, 12(3): 260 - 278

P. Mohindra, R. N. Sinha, R. J. Andrews and D. Khuntia


DOI: 10.2174/156800912799277494




Anti-Angiogenic Approaches to Malignant Gliomas

, 12(3): 279 - 288

R. Soffietti, E. Trevisan, L. Bertero, C. Bosa and R. Ruda


DOI: 10.2174/156800912799277584




Targeting Angiogenesis for Treatment of NSCLC Brain Metastases

, 12(3): 289 - 299

C. Schettino, M. A. Bareschino, A. Rossi, P. Maione, P. C. Sacco, G. Colantuoni, E. Rossi and C. Gridelli


DOI: 10.2174/156800912799277476




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science